TD Cowen Forecasts Strong Price Appreciation for MetLife (NYSE:MET) Stock

MetLife (NYSE:METGet Free Report) had its price objective raised by equities research analysts at TD Cowen from $97.00 to $99.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the financial services provider’s stock. TD Cowen’s price target would indicate a potential upside of 12.18% from the stock’s previous close.

Other analysts have also issued reports about the stock. Jefferies Financial Group boosted their target price on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Bank of America cut their price objective on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. Barclays decreased their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. Morgan Stanley cut their price target on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a report on Monday, August 19th. Finally, StockNews.com upgraded MetLife from a “hold” rating to a “buy” rating in a research report on Monday. Fourteen analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $88.62.

Get Our Latest Analysis on MetLife

MetLife Trading Up 0.6 %

MetLife stock opened at $88.25 on Wednesday. MetLife has a 52-week low of $62.89 and a 52-week high of $89.05. The company has a market cap of $61.11 billion, a P/E ratio of 17.79, a P/E/G ratio of 0.79 and a beta of 1.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The business has a 50-day simple moving average of $83.19 and a two-hundred day simple moving average of $76.46.

Hedge Funds Weigh In On MetLife

Several hedge funds have recently modified their holdings of the stock. MeadowBrook Investment Advisors LLC grew its stake in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. boosted its holdings in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC grew its position in shares of MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares in the last quarter. Peterson Financial Group Inc. bought a new stake in shares of MetLife in the third quarter worth about $30,000. Finally, Fortitude Family Office LLC lifted its position in shares of MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after buying an additional 266 shares in the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.

MetLife Company Profile

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.